Patrick DePaolo

Patrick DePaolo is a University Lecturer in Chemistry and Environmental Science at New Jersey Institute of Technology (NJIT). He holds a PhD in Chemical Biology from Stevens Institute of Technology (2021), along with an M.S. (2018) and B.S. (2017) in the same field. His research focuses on preclinical cancer drug discovery, particularly targeting the MAPK signal transduction pathway. He combines academic expertise with entrepreneurial ventures, such as owning Custom Lux PCs Inc. since 2020, and industry experience as a Research Scientist in Biophysics at Hotspot Therapeutics (2022–2023).

Education:

• Ph.D. in Chemical Biology, Stevens Institute of Technology, 2021
• M.S. in Chemical Biology, Stevens Institute of Technology, 2018
• B.S. in Chemical Biology, Stevens Institute of Technology, 2017

His teaching emphasizes preparing students for the biopharmaceutical industry. While no articles or awards are explicitly listed, his professional background highlights expertise in drug discovery and biophysical research.

Experience Highlights:

• Owner, Custom Lux PCs Inc. (since 2020)
• Research Scientist, Hotspot Therapeutics (2022–2023)